run a franchise footwear outlet
-
Franchise India Bureau Aug 06 2018 - 1 min readRegeneron Pharmaceuticals Inc has announced to invest $100 million in cancer drug developer bluebird bio Inc, and jointly the companies will develop new cell therapies for cancer. The investment will be at $238.10 per share, a premium of nearly 59 percent over bluebird's Friday closing price. Bluebird bio's shares were up about 7 pct at ...